Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00781664 · ClinicalTrials.gov registry record · Phase 1
Cumulative Irritation Test
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT00781664 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 44 participants.
The verdict
NCT00781664, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.
Interventions
- OTHER AN2718
- DRUG AN2718
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2008-10 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00781664
The ClinicalTrials.gov registry entry for NCT00781664 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AN2718 is the first listed.
NCT00781664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00781664 about?
NCT00781664 is a clinical study titled "Cumulative Irritation Test". The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.
What is the current status of trial NCT00781664?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2008-10. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00781664?
The interventions under investigation include: AN2718 (OTHER), AN2718 (DRUG).
Who is sponsoring clinical trial NCT00781664?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.